Tralokinumab Monotherapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials. J of Skin 2020, 4 (6), s101. https://doi.org/10.25251/skin.4.supp.101.